CITR Amends Preferred Stock, Bolsters Equity Structure

TL;DR

**CITR is aggressively restructuring its preferred stock, signaling a potential capital raise or conversion event that could significantly dilute common shareholders.**

AI Summary

General Enterprise Ventures, Inc. (CITR) filed an S-1/A, detailing significant amendments to its capital structure and ongoing financial activities. On March 29, 2024, the company amended and restated its Series A Convertible Preferred Stock, designating 10,000,000 shares with a par value of $0.0001. Subsequently, on March 17, 2025, CITR similarly amended and restated its Series C Convertible Preferred Stock, also designating 10,000,000 shares with a $0.0001 par value. The filing indicates a focus on equity financing, with 10,000,000 shares of Series A Preferred Stock and 10,000,000 shares of Series C Convertible Preferred Stock now defined. The company reported 2,450,138 shares of common stock outstanding as of March 31, 2025, with 97,545,388 shares authorized. Total liabilities were $10,102,266 as of March 31, 2025, including $6,881,722 in convertible notes. The company also disclosed $120,155 in consulting services for the quarter ended March 31, 2025, and $23,348 in subscription arrangements during the same period. Subsequent events include the issuance of 166,667 shares of Series C Preferred Stock for $100,000 in February 2025.

Why It Matters

This S-1/A filing reveals General Enterprise Ventures' strategic pivot towards refining its capital structure, particularly through preferred stock designations. For investors, the clear definition of 10,000,000 Series A and 10,000,000 Series C Convertible Preferred shares provides transparency on potential dilution and future financing mechanisms. Employees and customers might see this as a move to stabilize the company's financial foundation, potentially impacting long-term operational stability. In a competitive landscape, a well-defined capital structure can attract more robust investment, signaling a more mature approach to corporate finance compared to peers with less organized equity. The significant convertible note liabilities of $6,881,722, however, remain a key area of concern.

Risk Assessment

Risk Level: high — The risk level is high due to the significant amount of convertible preferred stock (10,000,000 Series A and 10,000,000 Series C shares) and substantial convertible note liabilities totaling $6,881,722. These instruments pose a considerable dilution risk to existing common shareholders upon conversion, as evidenced by the 97,545,388 authorized common shares compared to 2,450,138 outstanding. The company's total liabilities of $10,102,266 as of March 31, 2025, further highlight financial pressures.

Analyst Insight

Investors should scrutinize the conversion terms of CITR's Series A and Series C Preferred Stock and the $6,881,722 in convertible notes. Consider the potential for significant dilution to common shares and its impact on per-share value. Await further disclosures on how these preferred shares will be utilized or converted before making long-term investment decisions.

Financial Highlights

debt To Equity

N/A

revenue

$23,348

operating Margin

N/A

total Assets

N/A

total Debt

$6,881,722

net Income

N/A

eps

N/A

gross Margin

N/A

cash Position

N/A

revenue Growth

N/A

Revenue Breakdown

Key Numbers

• 10,000,000 — Series A Preferred Stock shares designated (Amended on March 29, 2024)
• 10,000,000 — Series C Convertible Preferred Stock shares designated (Amended on March 17, 2025)
• $0.0001 — Par value per preferred share (Applies to both Series A and Series C)
• 2,450,138 — Common stock shares outstanding (As of March 31, 2025)
• 97,545,388 — Authorized common shares (Indicates significant potential for dilution)
• $6.88M — Convertible note liabilities (As of March 31, 2025, a major liability)
• $10.10M — Total liabilities (As of March 31, 2025)
• $120,155 — Consulting services expense (For the quarter ended March 31, 2025)
• 166,667 — Series C Preferred Stock shares issued (In February 2025 for $100,000)

Key Players & Entities

• General Enterprise Ventures, Inc. (company) — Filer of S-1/A
• SEC (regulator) — Recipient of S-1/A filing
• $0.0001 (dollar_amount) — Par value of Series A and Series C Preferred Stock
• March 29, 2024 (date) — Date of Series A Convertible Preferred Stock amendment
• March 17, 2025 (date) — Date of Series C Convertible Preferred Stock amendment
• $6,881,722 (dollar_amount) — Convertible note liabilities as of March 31, 2025
• $10,102,266 (dollar_amount) — Total liabilities as of March 31, 2025
• $120,155 (dollar_amount) — Consulting services for Q1 2025
• $23,348 (dollar_amount) — Subscription arrangements for Q1 2025
• $100,000 (dollar_amount) — Proceeds from Series C Preferred Stock issuance in February 2025

FAQ

Risk Factors

• Significant Convertible Debt [high — financial]: As of March 31, 2025, the company has $6,881,722 in convertible note liabilities, representing a substantial portion of its total liabilities of $10,102,266. This debt could lead to significant dilution upon conversion.
• Potential for Shareholder Dilution [medium — financial]: With 97,545,388 authorized common shares and 2,450,138 outstanding as of March 31, 2025, there is significant room for future share issuance. The designation of 10,000,000 shares each for Series A and Series C Preferred Stock further increases this potential.
• Reliance on Equity Financing [medium — financial]: The company's capital structure amendments and the issuance of preferred stock indicate a reliance on equity financing. This can be a costly way to raise capital and may not be sustainable if market conditions change.
• Limited Operating History Disclosed [low — operational]: The S-1/A filing focuses on capital structure and recent financial activities. Detailed information on the company's core operations, product lines, and market penetration is not extensively provided, making it difficult to assess operational performance.

Industry Context

General Enterprise Ventures, Inc. operates within the Chemicals & Allied Products sector (SIC 2800). This industry is characterized by significant R&D investment, regulatory oversight, and competitive pricing pressures. Companies in this sector often focus on specialized chemical applications and industrial services.

Regulatory Implications

As a publicly traded company filing an S-1/A, General Enterprise Ventures, Inc. is subject to SEC regulations and reporting requirements. Amendments to its capital structure and disclosures of financial activities must comply with securities laws to ensure investor protection.

What Investors Should Do

1. Monitor future filings for details on revenue generation and profitability, as current disclosures are limited.
2. Assess the impact of convertible note conversions on potential shareholder dilution.
3. Evaluate the company's strategy for managing its significant liabilities.
4. Understand the specific rights and conversion features of the Series A and Series C Preferred Stock.

Key Dates

• 2024-03-29: Series A Convertible Preferred Stock amended and restated — Designated 10,000,000 shares of Series A Preferred Stock, impacting the company's equity structure.
• 2025-02-01: Issuance of Series C Preferred Stock — 166,667 shares issued for $100,000, indicating recent equity financing activity.
• 2025-03-17: Series C Convertible Preferred Stock amended and restated — Designated 10,000,000 shares of Series C Convertible Preferred Stock, further defining equity classes.
• 2025-03-31: Reporting period end for financial data — Provides the latest snapshot of the company's financial position, including liabilities and outstanding shares.

Glossary

S-1/A

An amendment to a registration statement filed with the SEC, typically used to update or correct information previously filed. (This filing provides updated details on General Enterprise Ventures, Inc.'s capital structure and financial activities.)

Convertible Preferred Stock

A class of preferred stock that can be converted into a specified number of common stock shares. (General Enterprise Ventures, Inc. has designated Series A and Series C Convertible Preferred Stock, which can impact future common stock dilution.)

Par Value

A nominal value assigned to a security by the issuer, often a very small amount for common and preferred stock. (The par value of $0.0001 for preferred shares is standard and does not reflect market value.)

Convertible Notes

Debt instruments that can be converted into equity (stock) of the issuing company. (A significant portion of CITR's liabilities ($6,881,722) are in the form of convertible notes, posing a potential dilution risk.)

Year-Over-Year Comparison

This S-1/A filing represents a significant update to the company's capital structure, particularly with the designation of Series A and Series C Preferred Stock. While specific comparative financial metrics like revenue growth or margin changes from a prior period are not detailed in the provided context, the increase in authorized shares and the substantial convertible note liabilities highlight a focus on financing and potential future dilution, which are key areas of change.

Filing Details

This Form S-1/A (Form S-1/A) was filed with the SEC on July 3, 2025 regarding General Enterprise Ventures, Inc. (CITR).

View full filing on EDGAR

View Full Filing

View this S-1/A filing on SEC EDGAR